CN Patent

CN116098864B — 一种利那洛肽干混悬剂及其制备方法

Assigned to Beijing Punuo Wang Kang Pharmaceutical Technology Co ltd · Expires 2023-06-09 · 3y expired

What this patent protects

本发明公开了一种利那洛肽干混悬剂及其制备方法。本发明干混悬剂包括活性成分利那洛肽、填充剂、助悬剂、崩解剂、pH调节剂、稳定剂、矫味剂、助流剂、着色剂。本发明利那洛肽干混悬剂采用粉末混合工艺，可避开湿法制粒过程，湿热条件对活性成分的影响；提高生产效率，制得的干混悬剂口感好，快速释放，提高患者用药的顺从性，尤其适用于存在吞咽不便或吞咽困难患者。本发明提供的利那洛肽干混悬剂稳定性好，制备工艺简便，易于工业化生产。

USPTO Abstract

本发明公开了一种利那洛肽干混悬剂及其制备方法。本发明干混悬剂包括活性成分利那洛肽、填充剂、助悬剂、崩解剂、pH调节剂、稳定剂、矫味剂、助流剂、着色剂。本发明利那洛肽干混悬剂采用粉末混合工艺，可避开湿法制粒过程，湿热条件对活性成分的影响；提高生产效率，制得的干混悬剂口感好，快速释放，提高患者用药的顺从性，尤其适用于存在吞咽不便或吞咽困难患者。本发明提供的利那洛肽干混悬剂稳定性好，制备工艺简便，易于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN116098864B
Jurisdiction
CN
Classification
—
Expires
2023-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Punuo Wang Kang Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.